New York State Common Retirement Fund Buys 3,200 Shares of The Clorox Company (NYSE:CLX)

New York State Common Retirement Fund raised its stake in The Clorox Company (NYSE:CLX) by 4.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 75,087 shares of the company’s stock after purchasing an additional 3,200 shares during the quarter. New York State Common Retirement Fund owned 0.06% of Clorox worth $11,057,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Corient Private Wealth LLC boosted its position in Clorox by 0.4% during the 4th quarter. Corient Private Wealth LLC now owns 28,652 shares of the company’s stock valued at $4,653,000 after buying an additional 117 shares during the period. Generali Asset Management SPA SGR bought a new position in shares of Clorox during the fourth quarter valued at about $940,000. Vinva Investment Management Ltd boosted its holdings in shares of Clorox by 147.7% during the fourth quarter. Vinva Investment Management Ltd now owns 6,627 shares of the company’s stock worth $1,070,000 after purchasing an additional 3,952 shares during the period. iA Global Asset Management Inc. bought a new stake in shares of Clorox in the fourth quarter worth about $2,768,000. Finally, Millstone Evans Group LLC purchased a new position in Clorox during the 4th quarter valued at about $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the stock in a transaction that occurred on Wednesday, May 7th. The shares were acquired at an average cost of $136.57 per share, with a total value of $546,280.00. Following the transaction, the director owned 4,000 shares of the company’s stock, valued at $546,280. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.57% of the stock is owned by company insiders.

Clorox Trading Down 0.8%

Clorox stock opened at $128.28 on Friday. The Clorox Company has a 12 month low of $117.35 and a 12 month high of $171.37. The company has a market capitalization of $15.81 billion, a price-to-earnings ratio of 23.03, a price-to-earnings-growth ratio of 3.39 and a beta of 0.51. The business’s fifty day simple moving average is $127.36 and its two-hundred day simple moving average is $141.35. The company has a current ratio of 0.74, a quick ratio of 0.44 and a debt-to-equity ratio of 13.07.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The business’s revenue for the quarter was down 8.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.71 EPS. As a group, equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

CLX has been the topic of several research analyst reports. JPMorgan Chase & Co. reduced their target price on Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 6th. Barclays set a $119.00 price objective on shares of Clorox and gave the company an “underweight” rating in a research report on Tuesday. Jefferies Financial Group dropped their target price on shares of Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research report on Thursday, June 26th. Evercore ISI set a $140.00 target price on shares of Clorox and gave the company an “underperform” rating in a research note on Tuesday, May 6th. Finally, Morgan Stanley decreased their price target on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $145.17.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.